APA (7th ed.) Citation

Rugo, H. S., Schmid, P., Tolaney, S. M., Dalenc, F., Marmé, F., Shi, L., . . . Cortes, J. (2024). Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial. The oncologist, 29(9), . https://doi.org/10.1093/oncolo/oyae088

Chicago Style (17th ed.) Citation

Rugo, Hope S., et al. "Health-related Quality of Life with Sacituzumab Govitecan in HR+/HER2− Metastatic Breast Cancer in the Phase III TROPiCS-02 Trial." The Oncologist 29, no. 9 (2024). https://doi.org/10.1093/oncolo/oyae088.

MLA (9th ed.) Citation

Rugo, Hope S., et al. "Health-related Quality of Life with Sacituzumab Govitecan in HR+/HER2− Metastatic Breast Cancer in the Phase III TROPiCS-02 Trial." The Oncologist, vol. 29, no. 9, 2024, https://doi.org/10.1093/oncolo/oyae088.